594 related articles for article (PubMed ID: 16271538)
1. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
Lau DT; Hewlett AT
Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
[TBL] [Abstract][Full Text] [Related]
2. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
4. Need for immunization against hepatotropic viruses in children with chronic liver disease.
Srivastava A; Mathias A; Yachha SK; Agarwal J; Aggarwal R
J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):393-7. PubMed ID: 24840513
[TBL] [Abstract][Full Text] [Related]
5. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
[TBL] [Abstract][Full Text] [Related]
6. Seroepidemiology of hepatitis A in patients with chronic liver disease.
Saab S; Lee C; Shpaner A; Ibrahim AB
J Viral Hepat; 2005 Jan; 12(1):101-5. PubMed ID: 15655056
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM
Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
9. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis A and B screening and vaccination rates among patients with chronic liver disease.
Ramirez JC; Ackerman K; Strain SC; Ahmed ST; de Los Santos MJ; Sears D
Hum Vaccin Immunother; 2016; 12(1):64-9. PubMed ID: 26836326
[TBL] [Abstract][Full Text] [Related]
11. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
Anand AC; Nagpal AK; Seth AK; Dhot PS
J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
[TBL] [Abstract][Full Text] [Related]
12. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to hepatitis A virus infection among chronic liver disease patients and healthy blood donors in Thailand.
Pramoolsinsap C; Attamasirul K; Busagorn N; Maneerat Y; Nuchprayoon C; Tanprasert S; Srivatanakul P; Theamboonlers A; Hirsch P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):91-5. PubMed ID: 10695795
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease.
Keeffe EB; Iwarson S; McMahon BJ; Lindsay KL; Koff RS; Manns M; Baumgarten R; Wiese M; Fourneau M; Safary A; Clemens R; Krause DS
Hepatology; 1998 Mar; 27(3):881-6. PubMed ID: 9500723
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients.
Arguedas MR; Johnson A; Eloubeidi MA; Fallon MB
Hepatology; 2001 Jul; 34(1):28-31. PubMed ID: 11431730
[TBL] [Abstract][Full Text] [Related]
16. Vaccination for hepatitis A virus is not required for patients with chronic liver disease in India.
Acharya SK; Batra Y; Saraya A; Hazari S; Dixit R; Kaur K; Bhatkal B; Ojha B; Panda SK
Natl Med J India; 2002; 15(5):267-8. PubMed ID: 12502138
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
19. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
20. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
